Top Markets
Coin of the day
Canntab Therapeutics Limited Canntab Therapeutics Limited

Canntab Therapeutics Limited

PILL
Rangering i aksjer #40577
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Aksjekurs
$0.0036163
Sist synkronisert: 2023-10-30
Markedsverdi
$118.21K
Endring (1 dag)
0.39%
Endring (1 år)
0.00%
Land
CA
Handel Canntab Therapeutics Limited (PILL)

Kategori

Pris PILL pris med markedsverdi på B
Canntab Therapeutics Limited Canntab Therapeutics Limited
PILL
$0.0036163
Markedsverdi av Canntab Therapeutics Limited(PILL)
Markedsverdi: $118.21K
Per August 2026 har Canntab Therapeutics Limited en markedsverdi på $118.21K. Dette gjør Canntab Therapeutics Limited til det 40577th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Canntab Therapeutics Limited fra 2011 til 2026
PILL sammenlignet med topp 5 mest populære stocks
Pris på PILL Eiendel B Markedsverdi for B Resultater
Canntab Therapeutics Limited Canntab Therapeutics Limited
$167,215 $118.21K
$5.466T +4,623,922,919.34%
Canntab Therapeutics Limited Canntab Therapeutics Limited
$136,324 $118.21K
$4.456T +3,769,719,240.95%
Canntab Therapeutics Limited Canntab Therapeutics Limited
$127,653 $118.21K
$4.173T +3,529,940,091.41%
Canntab Therapeutics Limited Canntab Therapeutics Limited
$112,820 $118.21K
$3.688T +3,119,777,964.04%
Canntab Therapeutics Limited Canntab Therapeutics Limited
$87,638.42 $118.21K
$2.865T +2,423,429,938.18%